Drug intelligence / Profile preview

propofol + fentanyl + remifentanil

Development stage
Phase 4
Lead developer
Attikon University Hospital
Modality
Small Molecules
Administration
Intravenous
01

Overview

OBA (Opioid-Based Anesthesia) refers to a specific anesthetic protocol used as the control arm in a clinical trial conducted by Attikon Hospital to evaluate postoperative pain management. This regimen consists of a combination of the intravenous sedative-hypnotic propofol and the synthetic opioids fentanyl and remifentanil. In this protocol, propofol is used for both induction and maintenance of anesthesia, while fentanyl is administered at induction and remifentanil is infused for maintenance. The protocol is designed to provide stable intraoperative anesthesia and analgesia through the activation of GABA-A receptors and mu-opioid receptors, respectively. It serves as the standard-of-care comparator against Opioid-Free Anesthesia (OFA) in patients undergoing transurethral urological surgery.

Other names
Opioid-Based AnesthesiaOBA protocolOpioid-based anesthesia (Attikon Hospital)
02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)SCN8A (NaV1.6)GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)

Beyond the preview

Go deeper on propofol + fentanyl + remifentanil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propofol + fentanyl + remifentanil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call